Hacker News
- mRNA vaccine-induced antibodies more effective than natural immunity vs. Covid https://www.nature.com/articles/s41598-022-06629-2 45 comments
- Vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2. The mRNA vaccinated plasma has 17-fold higher antibodies than the convalescent antisera, but also 16 time more potential in neutralizing RBD and ACE2 binding of both the original and N501Y mutation https://www.nature.com/articles/s41598-022-06629-2 1804 comments science
Linking pages
Linked pages
- Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of Severe Acute Respiratory Syndrome Coronavirus 2 Can Be Attributed to Changes in Testing | Clinical Infectious Diseases | Oxford Academic https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab638/6324310?redirectedFrom=fulltext 5618 comments
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2022483 1299 comments
- https://www.nejm.org/doi/pdf/10.1056/NEJMoa2101765?articleTools=true 528 comments
- Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine | The Journal of Infectious Diseases | Oxford Academic https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa152/5814216?searchresult=1 236 comments
- Creative Commons — Attribution 4.0 International — CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ 95 comments
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2026920 63 comments
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months | NEJM https://www.nejm.org/doi/10.1056/nejmoa2114583 58 comments
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2109072 56 comments
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2035389 18 comments
- https://doi.org/10.1126/science.abf4063 3 comments
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 1 comment
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034545 0 comments
- https://doi.org/10.1016/S0140-6736(20)31866-3 0 comments
- Waning Immunity after the BNT162b2 Vaccine in Israel | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2114228 0 comments
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2114114 0 comments
- Humoral Immune Response to SARS-CoV-2 in Iceland | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2026116 0 comments